StockVS

NASDAQ · USD

CDT Equity Inc. (CDTTW) Stock Analysis

CDT Equity Inc. (CDTTW) is a stock listed on NASDAQ and quoted in US Dollar.

CDTTW

$0.01

−$0.00 (−1.85%)

Sep 3, 2026 · Market close

This is a derivative instrument — a warrant on CDT Equity Inc. (CDTT) common stock.

Issuer fundamentals are shown on the issuer page, not here.

Price History

Hover for the daily close. The dotted line marks the period open.

CDTTW Key Statistics

As of Sep 3, 2026
Trading
Open
$0.01
Previous Close
$0.01
Day's Range
0.01–0.01
52-Week Range
0.01–0.01
Volume
15.11K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.45

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CDTTW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−3.64%
2025 (partial year)+0.00%

As of September 3, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About CDT Equity Inc.

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Visit website →